The close integration of immune and metabolic responses associated with obesity lead to the development of metabolic diseases such as insulin resistance, diabetes, and atherosclerosis. However, the endogenous molecules that signal metabolic stress and the mechanisms that sense and relay such signals to metabolic and immune response systems are incompletely understood. The double stranded RNA-activated protein kinase PKR is activated in response to pathogens and nutrients, and work by our laboratory and others suggests that PKR plays an important role in integrating signaling networks that modulate inflammation and the development of insulin resistance. Based on our preliminary data we propose that the study of PKR activation represents an opportunity to identify the metabolic signals and novel mechanisms at play in immunometabolic regulation. Therefore, the objective of this proposal is to characterize the endogenous lipids and RNAs that modulate PKR activity and the formation of the active PRK complex in the setting of metabolic stress, with the goal of translating these findings to a broader understanding of the molecular signals that contribute to the integration of metabolic stresses and inflammation in obesity. We believe that successful completion of this work has the potential to highlight new therapeutic targets and strategies for use in the fight against the epidemic of obesity and related pathologies.
More than 69% of adults in the U.S. suffer from being overweight or obese, conditions associated with increased risk of developing a number of metabolic diseases including diabetes, cardiovascular disease, asthma, and cancer. The research described in this proposal will investigate the molecular mediators that coordinate metabolic and inflammatory signaling in the establishment of insulin resistance, diabetes, and metabolic disease. These studies are highly relevant to the mission of the NIH because a deeper understanding of the molecular pathways that underlie the connection between obesity, diabetes, and metabolic disease may open doors to new therapeutic strategies for conditions that affect a majority of the population.
|Nakamura, Takahisa; Arduini, Alessandro; Baccaro, Brenna et al. (2014) Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes 63:526-34|
|Cao, Haiming; Sekiya, Motohiro; Ertunc, Meric Erikci et al. (2013) Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab 17:768-78|
|Gregor, Margaret F; Misch, Emily S; Yang, Ling et al. (2013) The role of adipocyte XBP1 in metabolic regulation during lactation. Cell Rep 3:1430-9|
|Oh, Raymond S; Pan, Wen-Chi; Yalcin, Abdullah et al. (2012) Functional RNA interference (RNAi) screen identifies system A neutral amino acid transporter 2 (SNAT2) as a mediator of arsenic-induced endoplasmic reticulum stress. J Biol Chem 287:6025-34|
|Fu, Suneng; Yang, Ling; Li, Ping et al. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473:528-31|
|Yecies, Jessica L; Zhang, Hui H; Menon, Suchithra et al. (2011) Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 14:21-32|
|Yang, Ling; Li, Ping; Fu, Suneng et al. (2010) Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 11:467-78|
|Nakamura, Takahisa; Furuhashi, Masato; Li, Ping et al. (2010) Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140:338-48|
|Hotamisligil, Gökhan S (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-17|
|Kars, Marleen; Yang, Ling; Gregor, Margaret F et al. (2010) Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59:1899-905|
Showing the most recent 10 out of 35 publications